Drug Trial Radar · NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Nov 9, 2021
Primary completion
Sep 19, 2025
Study completion Jul 2027
Sponsor
- Lead sponsor
- Cogent Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 9, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).
Conditions
- Advanced Systemic Mastocytosis (AdvSM)
- SM With an Associated Hematologic Neoplasm (SM-AHN)
- Mast Cell Leukemia (MCL)
- Aggressive Systemic Mastocytosis (ASM)
Interventions
bezuclastinibDrug
Bezuclastinib is administered as tablets to be taken orally, continuously in 28-day cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part I: Identify clinically active and tolerable exposures of bezuclastinib in patients with AdvSMTime frame: 18 months
- Part II: - Determine efficacy of bezuclastinib as measured by mIWG Objective Response Rate (ORR) - Confirm the exposure-response relationship of bezuclastinibTime frame: 18 months
Locations
42 sites in 14 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham (UAB) Hospital
Birmingham, Alabama · Active not recruiting
Mayo Clinic Arizona
Phoenix, Arizona · Recruiting
City of Hope Comprehensive Cancer Center
Duarte, California · Recruiting
UCLA Medical Center
Los Angeles, California · Recruiting
Stanford Cancer Institute
Stanford, California · Recruiting
Galiz Research
Hialeah, Florida · Withdrawn
Winship Cancer Institute - Emory University
Atlanta, Georgia · Recruiting
Rush University Medical Center
Chicago, Illinois · Withdrawn
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Columbia University Irving Medical Center
New York, New York · Withdrawn
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio · Active not recruiting
MUSC Health University Medical Center
Charleston, South Carolina · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Huntsman Cancer Institute - University of Utah Health
Salt Lake City, Utah · Recruiting
Nepean Hospital
Kingswood, New South Wales, Australia · Recruiting
Gold Coast University Hospital
Southport, Queensland, Australia · Recruiting
Peter MacCallum Cancer Centre
Melbourne N., Victoria, Australia · Recruiting
AKH Wien, Universitatsklinikum
Vienna, Austria · Active not recruiting
CHU de Liege
Liège, Belgium · Withdrawn
University of Alberta Hospital
Edmonton, Alberta, Canada · Recruiting
St. Michael's Hospital - Unity Health Toronto
Toronto, Ontario, Canada · Recruiting
Necker-Enfants Malades Hospital
Paris, France · Active not recruiting
Centre Hospitalier Universitaire (CHU) de Poitiers
Poitiers, France · Active not recruiting
Centre Hospitalier Universitaire (CHU) de Toulouse
Toulouse, France · Active not recruiting
University Hospital Aachen
Aachen, Germany · Active not recruiting
Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany · Active not recruiting
UKSH Campus Lubeck
Lübeck, Germany · Withdrawn
Universitätsklinikum Mannheim
Mannheim, Germany · Active not recruiting
IRCCS Azienda Ospedaliero Universitaria di Bologna
Bologna, Italy · Terminated
Azienda Ospedaliero Universitaria Careggi
Florence, Italy · Withdrawn
AOU San Giovanni di Dio e Ruggi dAragonia
Salerno, Italy · Active not recruiting
Azienda Ospidaleira Universitaria Integrata Verona
Verona, Italy · Withdrawn
University Medical Center Groningen
Groningen, Netherlands · Active not recruiting
Oslo University Hospital
Oslo, Norway · Active not recruiting
Public University Hospital No. 1 in Lublin
Lublin, Poland · Active not recruiting
Hospital Universitario Vall d'Hebron
Barcelona, Spain · Active not recruiting
Institut Català d'Oncologia - Hospital Duran i Reynals
Barcelona, Spain · Active not recruiting
Hospital Universitario Ramón y Cajal
Madrid, Spain · Active not recruiting
Universitätsspital Basel
Basel, Switzerland · Recruiting
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom · Recruiting
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.